Found: 4
Select item for more details and to access through your institution.
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1365, doi. 10.1093/jac/dkn420
- By:
- Publication type:
- Article
Clinical Outcome of Pneumococcal Bacteremia, In Vitro Resistance, and Antibiotic Therapy.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Epidemiological, Clinical, and Prognostic Differences between the Diseases Caused by Mycobacterium kansasii and Mycobacterium tuberculosis in Patients Infected with Human Immunodeficiency Virus: A Multicenter Study.
- Published in:
- Clinical Infectious Diseases, 2003, v. 37, n. 4, p. 584
- By:
- Publication type:
- Article
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 8, p. e84, doi. 10.1086/605677
- By:
- Publication type:
- Article